Delivery Order SPE2DR25D2101-SPE2DR26F49TY
Award Date 4/1/26
Potential Completion Date 4/22/26
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $20,878.16 delivery order to Amerisourcebergen Drug Corp on April 7, 2026, for Tavalisse 100 mg tablets (60-count units), with an ultimate completion date of April 28, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $10,439.07 delivery order to AmerisourceBergen Drug Corp on March 25, 2026, for 60 tablets of Tavalisse 100 mg, with an ultimate completion date of April 15, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The...
- The Defense Logistics Agency issued a $10,439.07 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Tavalisse 100 mg tablets (60-count units), with an ultimate completion date of April 13, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $20,806.83 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Tavalisse 100 mg tablets (60-count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate completion date is March 23, 2026. Pricing is firm fixed price with no...
- The Defense Logistics Agency issued a $10,439.07 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Tavalisse 100 mg tablets (60-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for Tavalisse 150 mg tablets (60-count), with a ceiling value of $10,367.76.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion is scheduled for March 18, 2026. The order is priced on a firm fixed-price basis with no set-aside applied.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tavalisse 150 mg tablets (60-count) with a contract ceiling value of $18,593.94. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and is scheduled for completion by October 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $10,439.07 for TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. Place of performance is Conshohocken, PA 19428. The order is firm fixed price with an ultimate completion date of March 3, 2026. The delivery order was issued under the parent DLA Troop Support Medical indefinite delivery contract (SPE2DX), a global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $20,878.16. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 19, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F49TYDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Tavalisse 100 mg tablets (60-count unit) with a ceiling value of $10,439.07 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 22, 2026. This delivery order was issued on a non-competitive, no-set-aside basis and calls against AmerisourceBergen's parent company Cencora, Inc.'s Defense Logistics Agency Troop Support Medical indefinite delivery contract, valued at up to $999,999,999.00 through December 31, 2031, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally.
Generated 7/2/26, 2:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 3/31/26 |